allergy banner

Videos


Articles


Citations: 3335

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Citations: 2330

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478

Citations: 1328

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 1300

A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force

Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824

Citations: 885

Position Paper - Allergen Standardization and Skin-Tests

Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54

Citations: 794

Allergenic pollen and pollen allergy in Europe

D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990

Citations: 760

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316

Citations: 757

The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887

Citations: 664

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948

Citations: 617

EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025

Citations: 1328

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 245

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 169

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 119

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 115

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 77

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 56

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Citations: 55

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 52

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

In search of the golden ratio for cannabis allergy: utility of specific allergen-to-total IgE ratios

Decuyper, I.I., Rihs, H.-P., Mertens, C.H., er al. Allergy. First published: 29 July 2021

Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma

Klein, M., Misme-Aucouturier, B., Cheminant, M.-A., et al. Allergy. First published: 29 July 2021

IL-10 induces IgG4 production in NOD-scid Il2rγnullmice humanized by engraftment of peripheral blood mononuclear cells

Cevhertas, L., Ma, S., Stanic, B., et al. Allergy. First published: 29 July 2021

Local inflammation enables a basophil-neuronal circuITCH in atopic dermatitis

López-Sanz, C., Jimenéz-Saiz, R. and Ehlers, A.M. Allergy. First published: 28 July 2021

One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence

Pfaar, O., Bousquet, J., Durham, S., et al. Allergy. First published: 27 July 2021

IRE1 and PERK signaling regulates inflammatory responses in a murine model of contact hypersensitivity

Klimek, L., Agache, I., Cooke, E., Jutel, M., Akdis, C.A. and O'Hehir, R. Allergy. First published: 27 July 2021

Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses

Karakoc Aydiner, E., Bilgic Eltan, S., Babayeva, R., et al. Allergy. First published: 27 July 2021

Low oxygen-levels decrease adaptive immune responses and ameliorate experimental asthma in mice

Hochgerner, M., Sturm, E.M., Schnoegl, D., et al. Allergy. First published: 26 July 2021

Newly defined allergens in the WHO/IUIS Allergen Nomenclature Database during 01/2019-03/2021

Sudharson, S., Kalic, T., Hafner, C. and Breiteneder, H. Allergy. First published: 26 July 2021

Prevention of infant eczema by neonatal Bacillus Calmette–Guérin vaccination: the MIS BAIR randomised controlled trial

Pittet, L.F., Messina, N.L., Gardiner, K., et al. Allergy. First published: 26 July 2021

Large scale regulatory T cells screening

Benamar, M. and Charbonnier, L.-M. Allergy. First published: 22 July 2021

The food, the bug, and the ugly: A recipe for food-induced gut pain

Rondeau, L., De Palma, G. and Caminero, A. Allergy. First published: 22 July 2021

Hypersensitivity Pneumonitis: Current Concepts in Pathogenesis, Diagnosis, and Treatment

B, H., Troy, L., Lee, C.T., Sperling, A., Strek, M. and Glaspole, I.Allergy. First published: 22 July 2021

Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study

Banerji, A., Bernstein, J.A., Johnston, D.T., et al. Allergy. First published: 21 July 2021

Evolution and Long-Term Outcomes of Combined Immunodeficiency Due to CARMIL2 Deficiency

Kolukisa, B., Baser, D., Akcam, B., et al. Allergy. First published: 20 July 2021

Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy

Heldner, A., Alessandrini, F., Russkamp, D., et al. Allergy First published: 20 July 2021

Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema

Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T. and Wedi, B. First published: 20 July 2021

Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study

Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 19 July 2021

Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database

Mota, D., Rama, T.A., Severo, M. and Moreira, A. Allergy. First published: 16 July 2021

Reduced IL-31 receptor alpha splice variant mRNA following allergen challenge in a canine model of atopic dermatitis

Craig, N., Ahrens, K., Wilkes, R. and Marsella, R. Allergy. First published: 13 July 2021

Early intervention and prevention of allergic diseases

Brough, H., Lanser, B.J., Sindher, S.B., et al. Allergy. First published: 13 July 2021

Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis

Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy First published: 12 July 2021

A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: perspectives for immune-based vaccines

Galati, D., Zanotta, S., Capitelli, L. and Bocchino, M. First published: 10 July 2021

An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen- specific immunotherapy

Zimmer, J., Schmidt, S., Kaul, S., et al. Allergy. First published: 9 July 2021

Molecular definition of SARS-CoV-2 RBD mutations: receptor affinity versus neutralization of receptor interaction

Vogel, M., Augusto, G.S., Chang, X., et al. Allergy. First published: 08 July 2021

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. First published: 03 July 2021

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Asthma and COVID-19: Is asthma a risk factor for severe outcomes?

Johnston, S.,L. Allergy. 2020; 75: 1543-1545

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapy

Alpan, O., Layhadi, J.A., Ulrik Sønder, S., Li, H. and Shamji, M.H. Allergy. 2021; 76: 1321-1324

The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease

Perkins, T.,N, Donnell, M.,L, Oury, T.,D. Allergy. 2021; 76: 1350– 1366

The global burden of illness of peanut allergy: A comprehensive literature review

Lieberman, J.,A, Gupta, R., Knibb, R.,C., Haselkorn, T., Tilles, S., Mack, D., P. and Poussel, G. et al. Allergy. 2021; 76: 1367– 1384

Butyrate as a bioactive human milk protective component against food allergy

Paparo, L, Nocerino, R, Ciaglia, E, et al. Allergy. 2021; 76: 1398– 1415

Predicting food allergy: The value of patient history reinforced

Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462

Identification of Pru du 6 as a potential marker allergen for almond allergy

Kabasser, S, Hafner, C, Chinthrajah, S, et al. Allergy. 2021; 76: 1463– 1472

Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry

Maris, I., Dölle-Bierke, S., Renaudin, J.-M., Lange, L., Koehli, A., Spindler, T. et al. Allergy. 2021; 76: 1517-1527

Pollen induces reactivation of latent herpesvirus and differentially affects infected and uninfected murine macrophages

Speidel, J.D., Gilles, S., Steer, B., Vafadari, B., Rauer, D., Traidl-Hoffmann, C. and Adler, H. Allergy. 2021; 76: 1539-1542

PIPE-cloned human IgE and IgG4 antibodies: New tools for investigating cow's milk allergy and tolerance

Pranger, C.L., Fazekas-Singer, J., Köhler, V.K., Pali-Schöll, I., Fiocchi, A., Karagiannis, S.N. et al. Allergy. 2021; 76: 1553-1556

Assessing the protective role of allergic disease in gastrointestinal tract cancers using Mendelian randomization analysis

Yuan, S., Vithayathil, M., Kar, S., Carter, P., Mason, A.M., Xie, S.-H., Burgess, S. and Larsson, S.C. Allergy. 2021; 76: 1559-1562

Trained immunity and allergy: State of the art and future perspectives

Wang, H., Song, J., Pan, L., Deng, Y.-K., Yao, Y., Wang, Z.-C. et al. Allergy. 2021; 76: 1565-1568

Elucidating the α-Gal syndrome at the molecular allergen level

Kiewiet, M.B.G., Grundström, J., Apostolovic, D., Andersson, M., Borres, M.P., Hamsten, C. et al. Allergy. 2021; 76: 1576-1578

The roadmap for allergology in Europe: The European training requirements for the specialty of allergology

Gerth van Wijk, R., Mülleneisen, N., Demoly, P., Olaguibel, J.M., Popov, T.A., Schmid-Grendelmeier, P. and Tsilochristou, O. Allergy. 2021; 76: 1588-1591

Junior Members Corner



Dear JMs,


The EAACI 2021 Annual Congress will be taking place on 10 - 12 July in a hybrid format, with both a physical part that will be held in Krakow both a digital part to allow anybody to attend safely. You are still on time to register by clicking here to have full live access to EAACI Hybrid Congress 2021 (3 days) and full access On Demand until December 31, 2021.

This is the main event of the Academy, and one of the biggest international dedicated to Allergy and Clinical Immunology. It gathers thousands of delegates from all around the world, and offers simultaneous sessions covering all aspects of our specialty.

Don't miss this opportunity and join us!

As every year the Junior Member Assembly (JMA) has organised some meetings to share knowledge and opportunity among JMs.
Here the Agenda with the highly suggested appointments:

- Monday, 28 June 2021, 15:00-16:00 CET: Open JM Business Meeting.

Invited guest Prof. Cezmi Akdis with the talk “Future direction of epithelial barrier research in the allergy and immunology field”. You can register by clicking here.


- Saturday, 10 July 2021, 14:00-15:30 CET: JMA Scientific Symposium.

Three excellent speeches on the theme "Approaching infants at high risk of allergic disease":
- Dr R. Jiménez-Saiz, “Understanding immunological mechanisms that confer a higher risk of allergy”;
- Dr M. M. Kelleher, “Infants at high risk of food allergy: nutritional and skin barrier repair interventions”;
- Dr I. Eguiluz-Gracia, “Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies”.

- Sunday, 11 July 2021, 14:00-15:30 CET: JMA Educational Session.

Composed of three very current speeches on "Lessons learned from COVID-19 pandemic":
- Dr A. DunnGalvin, “Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience”;
- “Infodemic and the lesson of the COVID-19 pandemic: how to tackle health-related misinformation”;
- Dr B. Moya, “COVID-19 vaccination: Separating facts from fiction for your patients”.

Save the dates!

Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!

Best regards,
The Junior Member Assembly


Social Media